NOVARTIS Stock London S.E.
Stocks
0HKE
CH0012005267
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| 10-02 | Healthcare Stocks Fall Slightly -- Healthcare Roundup | DJ |
| 10-02 | Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion | DJ |
| Market Cap | 267B 237B 221B 201B 380B 25,679B 383B 2,678B 1,038B 13,092B 1,001B 979B 42,091B | P/E 2026 * |
19.8x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 298B 265B 247B 225B 425B 28,703B 429B 2,993B 1,161B 14,634B 1,119B 1,095B 47,048B | EV / Sales 2026 * |
5.17x | EV / Sales 2027 * | 4.8x |
| Free-Float |
91.66% | Yield 2026 * |
3.09% | Yield 2027 * | 3.23% |
Last Transcript: NOVARTIS
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Karen Hale
CMP | Compliance Officer | 58 | 2025-04-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.76% | -3.39% | +26.07% | +58.90% | 410.8B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +71.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.69B 51.26B 47.78B 43.57B 82.21B 5,555B 82.95B 579B 225B 2,832B 217B 212B 9,106B | 61.43B 54.59B 50.88B 46.4B 87.55B 5,916B 88.33B 617B 239B 3,016B 231B 226B 9,697B |
| Net income | 14.23B 12.64B 11.78B 10.75B 20.28B 1,370B 20.46B 143B 55.4B 699B 53.42B 52.26B 2,246B | 15.79B 14.03B 13.08B 11.93B 22.51B 1,521B 22.71B 159B 61.49B 775B 59.28B 58B 2,493B |
| Net Debt | 31.4B 27.9B 26.01B 23.72B 44.75B 3,024B 45.15B 315B 122B 1,542B 118B 115B 4,957B | 28.22B 25.07B 23.37B 21.31B 40.22B 2,718B 40.58B 283B 110B 1,386B 106B 104B 4,454B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- NOVN Stock
- 0HKE Stock
Select your edition
All financial news and data tailored to specific country editions
